DJS ANTIBODIES
DJS Antibodies is discovering game-changing medicines to address recognised unmet medical need. Discovering new medicines is extremely difficult and most traditional methods fail. They have a breakthrough technology which overcomes this hurdle – revolutionising drug development. Early work, funded by Johnson&Johnson, has shown an unprecedented success rate in discovering lead antibodies and has lead to the development of lead programmes in both cancer and kidney disease.
DJS ANTIBODIES
Social Links:
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
Upper Heyford, Somerset, United Kingdom
Country:
United Kingdom
Website Url:
http://www.djsantibodies.com
Total Employee:
1+
Status:
Active
Total Funding:
8.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Capella BioScience
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sedgwick Claims Management Services
Sedgwick Claims Management Services investment in Venture Round - DJS Antibodies
Amgen Ventures
Amgen Ventures investment in Venture Round - DJS Antibodies
Oxford Science Enterprises
Oxford Science Enterprises investment in Venture Round - DJS Antibodies
LifeArc
LifeArc investment in Venture Round - DJS Antibodies
Innovate UK
Innovate UK investment in Grant - DJS Antibodies
Innovate UK
Innovate UK investment in Grant - DJS Antibodies
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - DJS Antibodies
Innovate UK
Innovate UK investment in Grant - DJS Antibodies
MassChallenge
MassChallenge investment in Non Equity Assistance - DJS Antibodies
Bizkaiko Foru Aldundia
Bizkaiko Foru Aldundia investment in Non Equity Assistance - DJS Antibodies
Official Site Inspections
http://www.djsantibodies.com
- Host name: 159.180.132.176
- IP address: 159.180.132.176
- Location: North Chicago United States
- Latitude: 42.325
- Longitude: -87.8561
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60064
More informations about "DJS Antibodies"
DJS Antibodies - Crunchbase Company Profile & Funding
DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel …See details»
Our Team – DJS Antibodies
At DJS our greatest asset is our team. People are at the heart of every idea, breakthrough, innovation, and development. As a team, we aspire to create the next generation of antibody …See details»
DJS Antibodies - LinkedIn
DJS Antibodies | 2,759 followers on LinkedIn. Unlocking immunology to deliver revolutionary medicines | At DJS we are developing novel therapeutics to treat chronic inflammatory diseases. We do ...See details»
DJS Antibodies 2025 Company Profile: Valuation, …
Information on acquisition, funding, cap tables, investors, and executives for DJS Antibodies. Use the PitchBook Platform to explore the full profile.See details»
Oxford Science Enterprises portfolio company DJS …
Oxford, UK: October 20, 2022: Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its unique partnership with the University of …See details»
DJS Antibodies - Products, Competitors, Financials, Employees ...
DJS Antibodies focuses on the development of novel therapeutics in the biotechnology sector, specifically targeting chronic inflammatory diseases. Use the CB Insights Platform to explore …See details»
DJS Antibodies - VentureRadar
"DJS Antibodies is building a pipeline of unique assets enabled by a world-leading platform for antibody discovery. HEPTAD is DJS Antibodies' proprietary antibody discovery technology …See details»
DJS Antibodies Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
DJS Antibodies is a company that is focused on creating new treatments for chronic inflammatory diseases. They achieve this by discovering and developing unique monoclonal antibodies that …See details»
DJS Antibodies, Ltd. | Insights
Who: AbbVie Inc. . and DJS Antibodies What: AbbVie will acquire DJS Antibodies, a private UK biotech focused on developing antibodies against hard-to-drug targets. Why: With the …See details»
DJS Antibodies - Craft
DJS Antibodies has 5 employees at their 1 location. See insights on DJS Antibodies including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
AbbVie Acquires DJS Antibodies, Further Strengthening …
Oct 20, 2022 Using HEPTAD, the company has generated a unique pipeline including DJS-002, a novel antibody targeting LPAR1 for the treatment of chronic fibrotic diseases. …See details»
AbbVie Acquires DJS Antibodies, Further Strengthening …
Oct 20, 2022 AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a …See details»
DJS Antibodies Ltd. (DJS Antibodies Ltd.) - 药物管线_专利_临床试 …
-- DJS Antibodies' DJS-002 is a potential first-in-class antibody directed to LPAR1, currently in investigational preclinical studies for the treatment of Idiopathic Pulmonary Fibrosis and other …See details»
What we do – DJS Antibodies
DJS-001 is a first-in-class programme targeting myeloid cell driven inflammatory disease. Through novel biological insights into the key drivers of myeloid cell recruitment and activation, we have …See details»
DJS Antibodies | VentureRadar
DJS Antibodies is building a pipeline of unique assets enabled by a world-leading platform for antibody discovery. HEPTAD is DJS Antibodies' proprietary antibody discovery technology …See details»
AbbVie Acquires DJS Antibodies, Further Strengthening …
Oct 20, 2022 <p>AbbVie (NYSE: ABBV) today announced the acquisition of DJS Antibodies Ltd ("DJS"), a privately-held UK-based biotechnology company dedicated to …See details»
DJS ANTIBODIES
We are looking for someone with a strong scientific background, and proven experience in project management to join our small dynamic team as our Oncology Project Manager. You will work …See details»
AbbVie Acquires DJS Antibodies, Further Strengthening …
Oct 20, 2022 AbbVie today announced the acquisition of DJS Antibodies. DJS’s lead program is DJS-002, a potential first-in-class lysophosphatidic acid (LPA) receptor 1 (LPAR1) antagonist …See details»
DJS Goes Carbon Neutral – DJS Antibodies
Jun 30, 2022 A major driver for many of us working in the biosciences, is having an opportunity to work on something that could have a positive impact on society. We come to work each day …See details»
Joe Illingworth, DJS Antibodies CSO speaks at BioTrinity 2022
Apr 22, 2022 DJS Antibodies CSO, Joe Illingworth is delighted to be speaking next week at BioTrinity 2022. As part of the session focusing on Inflammatory Disease Joe will be …See details»